Biblio

Found 122 results

Author Keyword Title Type [ Year

]

Filters: Keyword is Humans [Clear All Filters]

2005

Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L et al.. 2005. Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.. Hum Mol Genet. 14(3):447-60.

Gopalraj RK, Zhu H, Kelly JF, Mendiondo M, Pulliam JF, Bennett DA, Estus S. 2005. Genetic association of low density lipoprotein receptor and Alzheimer's disease.. Neurobiol Aging. 26(1):1-7.

Martin ER, Bronson PG, Li Y-J, Wall N, Chung R-H, Schmechel DE, Small G, Xu P-T, Bartlett J, Schnetz-Boutaud N et al.. 2005. Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease.. J Med Genet. 42(10):787-92.

Zhu H, Gopalraj RK, Kelly JF, Bennett DA, Estus S. 2005. Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimers disease.. Neurosci Lett. 381(1-2):36-41.

Boyles AL, Scott WK, Martin ER, Schmidt S, Li Y-J, Ashley-Koch A, Bass MP, Schmidt M, Pericak-Vance MA, Speer MC et al.. 2005. Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing.. Hum Hered. 59(4):220-7.

Slifer MA, Martin ER, Haines JL, Pericak-Vance MA. 2005. The ubiquilin 1 gene and Alzheimer's disease.. N Engl J Med. 352(26):2752-3;authorreply2752-3.

2004

Busby V, Goossens S, Nowotny P, Hamilton G, Smemo S, Harold D, Turic D, Jehu L, Myers A, Womick M et al.. 2004. Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.. Neuromolecular Med. 5(2):133-46.

van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW et al.. 2004. Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.

Nicodemus KK, Stenger JE, Schmechel DE, Welsh-Bohmer KA, Saunders AM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA et al.. 2004. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.. Neurogenetics. 5(4):201-8.

Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS et al.. 2004. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.. Nature. 429(6987):75-9.

Lee JH, Mayeux R, Mayo D, Mo J, Santana V, Williamson J, Flaquer A, Ciappa A, Rondon H, Estevez P et al.. 2004. Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.. Mol Psychiatry. 9(11):1042-51.

Myers AJ, Marshall H, Holmans P, Compton D, Crook RJP, Mander AP, Nowotny P, Smemo S, Dunstan M, Jehu L et al.. 2004. Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.. Am J Med Genet B Neuropsychiatr Genet. 124B(1):29-37.

2003

Li Y-J, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA et al.. 2003. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.. Hum Mol Genet. 12(24):3259-67.

Trembath Y, Rosenberg C, Ervin JF, Schmechel DE, Gaskell P, Pericak-Vance M, Vance J, Hulette CM. 2003. Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.. Acta Neuropathol. 105(5):484-8.

Scott WK, Hauser ER, Schmechel DE, Welsh-Bohmer KA, Small GW, Roses AD, Saunders AM, Gilbert JR, Vance JM, Haines JL et al.. 2003. Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.. Am J Hum Genet. 73(5):1041-51.

2002

Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB. 2002. Dementia and Alzheimer disease incidence: a prospective cohort study.. Arch Neurol. 59(11):1737-46.

Green RC, L Cupples A, Go R, Benke KS, Edeki T, Griffith PA, Williams M, Hipps Y, Graff-Radford N, Bachman D et al.. 2002. Risk of dementia among white and African American relatives of patients with Alzheimer disease.. JAMA. 287(3):329-36.

2001

Manton KG, Gu X. 2001. Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999.. Proc Natl Acad Sci U S A. 98(11):6354-9.

1997

O'Meara ES, Kukull WA, Sheppard L, Bowen JD, McCormick WC, Teri L, Pfanschmidt M, Thompson JD, Schellenberg GD, Larson EB. 1997. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.. Am J Epidemiol. 146(5):373-84.

1996

Kukull WA, Schellenberg GD, Bowen JD, McCormick WC, Yu CE, Teri L, Thompson JD, O'Meara ES, Larson EB. 1996. Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.. J Clin Epidemiol. 49(10):1143-8.

1993

Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.. Neurology. 43(2):250-60.

1984

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.. Neurology. 34(7):939-44.